Literature DB >> 10366125

An aggressive form of polyarticular arthritis in a man with CD154 mutation (X-linked hyper-IgM syndrome).

E A Webster1, A Y Khakoo, W J Mackus, M Karpusas, D W Thomas, A Davidson, C L Christian, S Lederman.   

Abstract

Hyper-IgM syndrome (HIM) is a rare immunodeficiency disorder that has been associated with the development of symptoms and clinical features characteristic of rheumatoid arthritis (RA). We describe a patient with HIM and severe erosive arthritis with prominent nodules in the absence of detectable serum rheumatoid factor. Because HIM results from defects in either T cell CD154 (CD40 ligand) expression or abnormal CD40 signaling, the molecular basis of the patient's disease was analyzed. Activated CD4+ T cells failed to express surface CD154 protein, and molecular analysis of CD154 complementary DNA revealed a nucleotide transversion resulting in the nonconservative amino acid substitution G-D at amino acid 257. This case indicates that defective CD154-dependent CD40 signaling can be associated with susceptibility to a severe inflammatory arthritis that has both similarities to and differences from idiopathic RA.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10366125     DOI: 10.1002/1529-0131(199906)42:6<1291::AID-ANR29>3.0.CO;2-#

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  3 in total

1.  TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.

Authors:  Reiko Horai; Akiko Nakajima; Katsuyoshi Habiro; Motoko Kotani; Susumu Nakae; Taizo Matsuki; Aya Nambu; Shinobu Saijo; Hayato Kotaki; Katsuko Sudo; Akihiko Okahara; Hidetoshi Tanioka; Toshimi Ikuse; Naoto Ishii; Pamela L Schwartzberg; Ryo Abe; Yoichiro Iwakura
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

2.  IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist.

Authors:  Susumu Nakae; Shinobu Saijo; Reiko Horai; Katsuko Sudo; Shigeo Mori; Yoichiro Iwakura
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

Review 3.  Autoimmunity in hyper-IgM syndrome.

Authors:  Adriana A Jesus; Alberto J S Duarte; João B Oliveira
Journal:  J Clin Immunol       Date:  2008-02-02       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.